JP2002520292A5 - ヒト成長因子と組み合わせた脈管形成剤としてのコンポーネントｂの使用 - Google Patents
ヒト成長因子と組み合わせた脈管形成剤としてのコンポーネントｂの使用 Download PDFInfo
- Publication number
- JP2002520292A5 JP2002520292A5 JP2000558838A JP2000558838A JP2002520292A5 JP 2002520292 A5 JP2002520292 A5 JP 2002520292A5 JP 2000558838 A JP2000558838 A JP 2000558838A JP 2000558838 A JP2000558838 A JP 2000558838A JP 2002520292 A5 JP2002520292 A5 JP 2002520292A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- growth factor
- combination
- human growth
- angiogenic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003102 growth factor Substances 0.000 title description 4
- 239000003795 chemical substances by application Substances 0.000 title description 3
- 230000002491 angiogenic Effects 0.000 title description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 102100008634 FGF2 Human genes 0.000 description 1
- 101700082364 FGF2 Proteins 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 206010068760 Ulcers Diseases 0.000 description 1
- 102100015249 VEGFA Human genes 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000546 pharmaceutic aid Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 200000000019 wound Diseases 0.000 description 1
Description
【特許請求の範囲】
【請求項１】 ヒト成長因子と組み合わせた脈管形成剤として使用されるコンポーネントＢ。
【請求項２】 体内の何れかの組織に対する創傷、潰瘍および他の外傷性損傷の治療のために使用される、請求項１記載のコンポーネントＢ。
【請求項３】 コンポーネントＢおよびヒト成長因子を活性成分として薬学上受容可能な賦形剤と共に含む、瘢痕形成剤として有用な薬剤組成物。
【請求項４】 単一投与用量にて２つの活性成分が存在する、請求項３記載の薬剤組成物。
【請求項５】 別々の投与用量にて２つの活性成分が各々存在する、請求項３記載の薬剤組成物。
【請求項６】 ヒト成長因子がｂＦＧＦまたはＶＥＧＦである、請求項３乃至５の何れか１項記載の薬剤組成物。
【請求項１】 ヒト成長因子と組み合わせた脈管形成剤として使用されるコンポーネントＢ。
【請求項２】 体内の何れかの組織に対する創傷、潰瘍および他の外傷性損傷の治療のために使用される、請求項１記載のコンポーネントＢ。
【請求項３】 コンポーネントＢおよびヒト成長因子を活性成分として薬学上受容可能な賦形剤と共に含む、瘢痕形成剤として有用な薬剤組成物。
【請求項４】 単一投与用量にて２つの活性成分が存在する、請求項３記載の薬剤組成物。
【請求項５】 別々の投与用量にて２つの活性成分が各々存在する、請求項３記載の薬剤組成物。
【請求項６】 ヒト成長因子がｂＦＧＦまたはＶＥＧＦである、請求項３乃至５の何れか１項記載の薬剤組成物。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98112775 | 1998-07-09 | ||
| EP98112775.6 | 1998-07-09 | ||
| PCT/EP1999/004605 WO2000002579A2 (en) | 1998-07-09 | 1999-07-02 | Component b as angiogenic agent in combination with human growth factors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002520292A JP2002520292A (ja) | 2002-07-09 |
| JP2002520292A5 true JP2002520292A5 (ja) | 2006-08-03 |
Family
ID=8232248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000558838A Pending JP2002520292A (ja) | 1998-07-09 | 1999-07-02 | ヒト成長因子と組み合わせた血管形成剤としてのコンパウンドｂの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6855684B2 (ja) |
| EP (1) | EP1093380B1 (ja) |
| JP (1) | JP2002520292A (ja) |
| AT (1) | ATE224200T1 (ja) |
| AU (1) | AU765600B2 (ja) |
| CA (1) | CA2336773C (ja) |
| DE (1) | DE69903037T2 (ja) |
| DK (1) | DK1093380T3 (ja) |
| ES (1) | ES2184480T3 (ja) |
| IL (2) | IL140778A0 (ja) |
| PT (1) | PT1093380E (ja) |
| WO (1) | WO2000002579A2 (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2184480T3 (es) * | 1998-07-09 | 2003-04-01 | Applied Research Systems | Componente b como agente angiogenico en combinacion con factores de crecimiento humano. |
| AU2001291019A1 (en) | 2000-09-15 | 2002-03-26 | Genvec, Inc. | Method of modulating neovascularization |
| AU2004229237B2 (en) | 2003-04-16 | 2009-06-04 | Merck Serono Sa | Use of SLURP-1 for treating diseases related to acetylcholine receptors dysfunction |
| WO2006060803A2 (en) * | 2004-12-03 | 2006-06-08 | Polnox Corporation | One pot process for making polymeric antioxidants |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1257184B (it) * | 1992-12-22 | 1996-01-10 | Applied Research Systems | Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale |
| AU727618B2 (en) * | 1996-04-24 | 2000-12-14 | Laboratoires Serono Sa | Component B as cicatrizant |
| ES2184480T3 (es) * | 1998-07-09 | 2003-04-01 | Applied Research Systems | Componente b como agente angiogenico en combinacion con factores de crecimiento humano. |
-
1999
- 1999-07-02 ES ES99934563T patent/ES2184480T3/es not_active Expired - Lifetime
- 1999-07-02 IL IL14077899A patent/IL140778A0/xx active IP Right Grant
- 1999-07-02 PT PT99934563T patent/PT1093380E/pt unknown
- 1999-07-02 AT AT99934563T patent/ATE224200T1/de active
- 1999-07-02 CA CA002336773A patent/CA2336773C/en not_active Expired - Fee Related
- 1999-07-02 DK DK99934563T patent/DK1093380T3/da active
- 1999-07-02 WO PCT/EP1999/004605 patent/WO2000002579A2/en active IP Right Grant
- 1999-07-02 EP EP99934563A patent/EP1093380B1/en not_active Expired - Lifetime
- 1999-07-02 DE DE69903037T patent/DE69903037T2/de not_active Expired - Lifetime
- 1999-07-02 AU AU50306/99A patent/AU765600B2/en not_active Ceased
- 1999-07-02 JP JP2000558838A patent/JP2002520292A/ja active Pending
-
2001
- 2001-01-08 IL IL140778A patent/IL140778A/en not_active IP Right Cessation
- 2001-01-09 US US09/756,185 patent/US6855684B2/en not_active Expired - Fee Related
-
2004
- 2004-12-10 US US11/008,175 patent/US7223732B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
| IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
| JP2001515712A5 (ja) | ||
| MXPA02002895A (es) | Tratamiento topico de infecciones por estreptococcus. | |
| Hunt et al. | Early tangential excision and immediate mesh autografting of deep dermal hand burns | |
| IL139231A0 (en) | Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract | |
| BRPI0108435B8 (pt) | formulação e uso de entecavir de baixa dose | |
| BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
| JP2002528502A5 (ja) | ||
| AR013506A1 (es) | Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida | |
| IL211288A (en) | Medical vaginal preparations to reduce or relieve uterine rhythm, and use of anti-arrhythmic therapy in the preparation of vaginal drugs to reduce or relieve uterine rhythm | |
| JP2002532432A5 (ja) | ||
| WO2000021548A3 (en) | Angiogenically effective unit dose of fgf and method of administering | |
| WO2005007072A3 (en) | Methods and pharmaceutical compositions for healing wounds | |
| JP2001510795A5 (ja) | ||
| PT1069902E (pt) | Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes | |
| WO1999026589A3 (en) | Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation | |
| JP2004537500A5 (ja) | ||
| WO2001089536A3 (en) | Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders | |
| EP2138175A3 (en) | Formulations comprising valsartan for treating diabetes or microalbuminuria | |
| AR012731A1 (es) | Uso de un derivado de taxano para la preparacion de una composicion farmaceutica , uso de un agente mejorador de la biodicponibilidad de dicho derivado forma de dosificacion oral y conjunto afrmaceutico que lo comprende y metodo para formar a un agente activo biodisponible. | |
| EP1304108A3 (en) | Anti-arrhythmic composition and methods of treatment | |
| JP2002520292A5 (ja) | ヒト成長因子と組み合わせた脈管形成剤としてのコンポーネントｂの使用 | |
| CA2045605A1 (en) | Treatment of leukocyte dysfunction with gm-csf | |
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 |